Ethics and Global Governance of Human Germline Genome Editing: The Problem of Techno-Scientific Colonialist Paternalism
By Gabriela Arguedas-Ramírez,
CRISPR Journal (paywall)
| 04. 21. 2020
Abstract
I want to enrich the debate about the ethics and governance of human germline editing (HGE) by emphasizing an underappreciated, yet important, set of concerns regarding exclusionary practices, norms, and efforts that impede a broader discussion about the subject. The possibility for establishing a binding, global, regulatory framework is influenced by economic and geopolitical factors as well as historical processes and sociopolitical problems, such as anti-scientific social movements and the politicization of science. Likewise, it is influenced by different understanding, epistemic resources, and goals between the CRISPR/genome editing community and the rest of society. In this Perspective, I explain the concept of “techno-scientific colonialist paternalism” and why it negatively affects our discussion around HGE. I also discuss the pitfalls of scientific self-regulation, and finally, I advocate that the implementation of HGE should cease to allow time and care for a thoughtful global discussion to emerge.
Related Articles
The Biden-Harris Administration is sure to have a very different approach to science policy than its predecessor. President Biden has always stressed the importance of science and as a symbol of it has installed a portrait of Benjamin Franklin in the Oval Office, placed near a moon rock, as well as busts and paintings representing civil rights activism and other historic events.
The week before his inauguration, he made seven appointments or nominations (some require Congressional approval) under the specific category of Science,...
The new Biden-Harris Administration faces a number of harrowing challenges in which science and technology policies will be critical. Along with the devastating COVID pandemic and the climate crisis, it will have to grapple with important decisions about US federal policy on heritable genome editing.
The Center for Genetics and Society will continue to track, and hope to influence, policy developments related to heritable genome editing that take shape in the White House, Congress, the National Institutes of Health, the...
By Sharon Begley, STAT | 01.06.2021
Biologists tend not to discuss experimental results on a handful of cells and a single solitary mouse — too preliminary, too sketchy. David Liu of the Broad Institute therefore had no plans to present such findings, which he’d peeked at...
By Francis S. Collins, M.D., Ph.D., Jennifer A. Doudna, Ph.D., Eric S. Lander, Ph.D., and Charles N. Rotimi, Ph.D., The New England Journal of Medicine | 01.07.2021
The breathtaking progress in molecular genetics that has occurred over the past five decades and the transition to genomic medicine would have been difficult to imagine in 1970, when the Institute of Medicine (IOM), now the National Academy of Medicine...